12 completed. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 12 |
Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PREPARE-iVAC Trial COVID-19 vaccination - COVID-19 Vaccines, Varicella Zoster Vaccine | Phase 4 | Completed | University Medical Center Groningen | 110 | 2023-08-22 | 2024-03-04 |
| Immune Monitoring to Facilitate Belatacept Monotherapy Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression | Phase 4 | Completed | Massachusetts General Hospital | 17 | 2020-02-11 | 2023-12-04 |
| Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients Tacrolimus - Immunosuppression, Stem Cell Transplant | Phase 4 | Completed | Mayo Clinic | 10 | 2019-06-17 | 2020-08-07 |
| Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Tacrolimus Extended Release Capsule, Mycophenolate mofetil, Prednisone - Immunosuppression | Phase 4 | Completed | Medical University of South Carolina | 25 | 2017-05-05 | 2019-12-26 |
| Zinc Supplementation on Cellular Immunity in Thalassemia Major Zinc Sulfate, Sucrose Syrup - Thalassemia, Splenectomy; Status | Phase 4 | Completed | Fakultas Kedokteran Universitas Indonesia | 58 | 2013-09-01 | 2017-04-17 |
| Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk Once Daily Tacrolimus, Twice Daily Tacrolimus - Immunosuppression, Cardiovascular Diseases | Phase 4 | Completed | University of Saskatchewan | 36 | 2012-10-01 | 2018-01-08 |
| Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS Mycophenolate sodium, Pantoprazole, Mycophenolate mofetil - Transplantation, Immunosuppression | Phase 4 | Completed | Klemens Budde | 20 | 2012-01-01 | 2019-02-21 |
| Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant Everolimus - Renal Transplant Rejection, Immunosuppression | Phase 4 | Completed | Andre Barreto Pereira | 30 | 2011-01-01 | 2020-02-07 |
| The Vienna Prograf and Endothelial Progenitor Cell Extension Study Tacrolimus - Immunosuppression, Renal Failure | Phase 4 | Completed | Medical University of Vienna | 87 | 2008-03-01 | 2018-11-23 |
| Study of Rituximab to Treat Chronic Renal Transplant Rejection Rituximab, Control arm - Kidney Transplantation, Graft Rejection | Phase 4 | Completed | King's College London | 62 | 2007-01-01 | 2020-03-05 |
| Influenza Vaccination in Immunocompromized Patients Virosomal influenza vaccine, Subunit influenza vaccine - Immunosuppression | Phase 4 | Completed | Insel Gruppe AG, University Hospital Bern | 304 | 2005-10-01 | 2008-11-03 |
| Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients Tacrolimus, combination therapy - Immunosuppression | Phase 4 | Completed | Newark Beth Israel Medical Center | 150 | 2004-04-01 | 2015-05-28 |
Acquired Immunodeficiency Syndrome (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Cytomegalovirus Infections (1) · Influenza, Human (1) · Rejection, Psychology (1) · Renal Insufficiency (1) · Thalassemia (1)
Infections (2) · Urogenital Diseases (2) · Virus Diseases (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Behavior (1) · Blood-Borne Infections (1) · Cardiovascular Diseases (1) · Communicable Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1)
Tacrolimus (5) · Mycophenolic Acid (4) · Everolimus (2) · Prednisone (2) · Abatacept (1) · Adrenal Cortex Hormones (1) · Combined Modality Therapy (1) · Methylprednisolone (1) · Pantoprazole (1) · Rituximab (1) · Sirolimus (1) · Zinc Sulfate (1) · heterologous prime boost COVID-19 vaccination (1)
Andre Barreto Pereira (1) · Fakultas Kedokteran Universitas Indonesia (1) · Insel Gruppe AG, University Hospital Bern (1) · King's College London (1) · Klemens Budde (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · Medical University of South Carolina (1) · Medical University of Vienna (1) · Newark Beth Israel Medical Center (1) · University Medical Center Groningen (1) · University of Saskatchewan (1)
United States (4) · Brazil (1) · Canada (1) · Germany (1) · Indonesia (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
Ahmed Shoker, MD (1) · Andre B Pereira, PhD (1) · Anthony Dorling, PhD FRCP (1) · David A Baran, MD (1) · Gere Sunder-Plassmann, MD (1) · Hannah Gilligan, MD (1) · Heather May, Pharm. D., R. Ph. (1) · James Fleming, PharmD (1) · Jan-Stephan F Sanders, MD PhD (1) · John M Evison, MD (1) · Klemens Budde, Prof Dr (1) · Teny T Sari, M.D., PhD (1)
PMID 17919618, PMID 19361304, PMID 21216835, PMID 31266056, PMID 32117242, PMID 33593135
2023 (1)